Duquesne Family Office Increased Its Nektar Therapeutics (NKTR) Position; Rignet (RNET) Has 1.13 Sentiment

November 14, 2017 - By Maria Brooks

RigNet, Inc. provides customized systems and solutions serving clients with data networking and operational requirements. The company has market cap of $265.18 million. The Firm provides voice and data

network, video conferencing and monitoring, crew welfare, asset and weather monitoring, and real-time data services. It currently has negative earnings. It operates through two divisions: Managed Services, and Systems Integration and Automation (SI&A).

Duquesne Family Office Llc increased Nektar Therapeutics (NKTR) stake by 75.2% reported in 2017Q2 SEC filing. Duquesne Family Office Llc acquired 500,500 shares as Nektar Therapeutics (NKTR)’s stock rose 44.66%. The Duquesne Family Office Llc holds 1.17 million shares with $22.80 million value, up from 665,600 last quarter. Nektar Therapeutics now has $6.23B valuation. The stock increased 6.63% or $2.46 during the last trading session, reaching $39.56. About 5.92 million shares traded or 193.07% up from the average. Nektar Therapeutics (NASDAQ:NKTR) has risen 41.52% since November 14, 2016 and is uptrending. It has outperformed by 24.82% the S&P500.

Among 9 analysts covering Nektar Therapeutics (NASDAQ:NKTR), 9 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Nektar Therapeutics had 18 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Wednesday, November 8. Aegis Capital initiated the shares of NKTR in report on Tuesday, November 8 with “Buy” rating. The stock of Nektar Therapeutics (NASDAQ:NKTR) has “Buy” rating given on Thursday, November 9 by Canaccord Genuity. Aegis Capital maintained Nektar Therapeutics (NASDAQ:NKTR) rating on Monday, June 5. Aegis Capital has “Buy” rating and $2700 target. TheStreet downgraded the shares of NKTR in report on Wednesday, August 26 to “Hold” rating. The rating was maintained by Roth Capital with “Buy” on Wednesday, August 9. As per Tuesday, July 18, the company rating was maintained by J.P. Morgan. The company was maintained on Tuesday, May 30 by Roth Capital. As per Thursday, January 7, the company rating was maintained by Piper Jaffray. The stock of Nektar Therapeutics (NASDAQ:NKTR) earned “Buy” rating by Roth Capital on Thursday, July 20.

Since May 15, 2017, it had 0 insider buys, and 1 sale for $1.96 million activity. Shares for $1.96M were sold by Nicholson John on Wednesday, June 7. Thomsen Jillian B. sold $51,827 worth of stock or 2,651 shares. Doberstein Stephen K sold 1,701 shares worth $33,255. On Tuesday, May 16 ROBIN HOWARD W sold $163,985 worth of Nektar Therapeutics (NASDAQ:NKTR) or 8,388 shares. $62,149 worth of stock was sold by Labrucherie Gil M on Tuesday, May 16. CHESS ROBERT sold 5,000 shares worth $98,950. 2,959 Nektar Therapeutics (NASDAQ:NKTR) shares with value of $57,848 were sold by Hora Maninder.

Investors sentiment increased to 1.89 in 2017 Q2. Its up 0.72, from 1.17 in 2017Q1. It improved, as 17 investors sold NKTR shares while 40 reduced holdings. 25 funds opened positions while 83 raised stakes. 147.16 million shares or 3.57% more from 142.09 million shares in 2017Q1 were reported. 1.40M were accumulated by Artal Group Incorporated Sa. World Asset Management Inc reported 10,167 shares. Ameritas Partners, Nebraska-based fund reported 13,011 shares. Metropolitan Life Insur Company holds 0.01% in Nektar Therapeutics (NASDAQ:NKTR) or 99,566 shares. Alps holds 140,043 shares or 0.02% of its portfolio. Shell Asset Mngmt stated it has 0.02% of its portfolio in Nektar Therapeutics (NASDAQ:NKTR). First Republic Inv Mngmt accumulated 20,926 shares or 0% of the stock. Leisure Mgmt reported 10,553 shares. Teacher Retirement Sys Of Texas reported 0% of its portfolio in Nektar Therapeutics (NASDAQ:NKTR). Arizona State Retirement Sys stated it has 0.02% in Nektar Therapeutics (NASDAQ:NKTR). Credit Suisse Ag invested 0.01% in Nektar Therapeutics (NASDAQ:NKTR). Westfield Cap LP owns 3.77M shares or 0.63% of their US portfolio. Paradigm Asset Management Ltd stated it has 0% of its portfolio in Nektar Therapeutics (NASDAQ:NKTR). Balyasny Asset Mngmt Ltd Com owns 511,013 shares. Employees Retirement Association Of Colorado has 30,748 shares for 0% of their portfolio.

Cannell Capital Llc holds 1.28% of its portfolio in RigNet Inc for 280,410 shares. Kohlberg Kravis Roberts & Co. L.P. owns 4.75 million shares or 0.92% of their US portfolio. Moreover, Arrowmark Colorado Holdings Llc has 0.53% invested in the company for 2.69 million shares. The Minnesota-based Punch & Associates Investment Management Inc. has invested 0.33% in the stock. Tfs Capital Llc, a Pennsylvania-based fund reported 48,331 shares.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>